Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company based in San Diego that specializes in the discovery, development, and commercialization of innovative therapeutic products targeting significant unmet medical needs. Founded by former executives from Receptos, the company focuses on areas such as immunology, inflammation, fibrosis, and oncology. Its pipeline includes several promising candidates: Seralutinib, aimed at addressing pulmonary arterial hypertension; GB004, for inflammatory bowel disease; GB1275, targeting various oncology indications; and GB001, designed for moderate-to-severe eosinophilic asthma. Gossamer Bio's strategy involves leveraging a rich in-licensing environment to enhance its therapeutic offerings, supported by a team recognized for their successful track record in drug development.
Top Stages
1 past transactions
Adhaere Pharmaceuticals
Acquisition in 2019
Adhaere Pharmaceuticals is a biopharmaceutical company based in Skokie, Illinois, specializing in the development of innovative therapeutics. The company is dedicated to targeting adhesion receptors on leukocytes, which plays a crucial role in the development of its drug pipeline. Adhaere Pharmaceuticals aims to address significant unmet medical needs by creating targeted treatments for various conditions, including solid tumors, inflammatory diseases, and autoimmune disorders. Through its research and development efforts, the company seeks to enhance therapeutic outcomes for patients suffering from these challenging health issues.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.